Global Medical REIT Inc.GMRE
| Aug 31, 2012 | Aug 31, 2013 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|
| Net income | -50,108 | -45,338 | - | - | - | - | - | - | - | 20 | 22 | 7 |
|---|
| Depreciation, Total | - | - | 659,671 | 2 | 8 | 14 | 19 | 27 | 34 | 40 | 41 | 40 |
|---|
| Amortization of Leased Asset | - | - | - | - | - | - | 6 | 10 | 13 | 17 | 17 | 14 |
|---|
| Amortization of above market leases, net | - | - | - | -994 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
|---|
| Amortization of Other Deferred Charges | - | - | - | - | - | - | 1 | 1 | 2 | 2 | 2 | 2 |
|---|
| Share-based Compensation | - | - | - | 2 | 2 | 3 | 3 | 5 | 6 | 5 | 4 | 5 |
|---|
| Noncash Merger Related Costs | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|---|
| Reserve for uncollectible accounts | - | - | - | - | - | - | - | 1 | 0 | - | 1 | 1 |
|---|
| Gain on sale of investment properties | - | - | - | - | - | - | - | - | 1 | 7 | 16 | 4 |
|---|
| Impairment of investment property | - | - | - | - | - | - | - | - | - | - | - | 2 |
|---|
| Equity loss from unconsolidated joint venture | - | - | - | - | - | - | - | - | - | - | - | 0 |
|---|
| Loss on extinguishment of debt | - | - | - | - | - | - | - | - | - | - | -1 | - |
|---|
| Other | - | - | - | - | - | - | -0 | 0 | -0 | -0 | -0 | -0 |
|---|
| Tenant receivables | - | - | - | 212,435 | 0 | 2 | 2 | 2 | 1 | 3 | -0 | 1 |
|---|
| Deferred assets | - | - | -93,646 | 681,242 | 3 | 6 | 5 | 6 | 5 | 4 | 3 | 2 |
|---|
| Other assets and liabilities | - | - | - | - | 0 | 0 | 0 | 0 | -0 | -1 | -1 | -2 |
|---|
| Accounts payable and accrued expenses | - | - | - | -39,509 | 1 | 2 | 1 | 2 | 2 | 4 | -2 | 3 |
|---|
| Security deposits | - | - | - | 719,592 | 1 | 2 | 2 | 0 | 0 | 1 | -2 | -0 |
|---|
| Net cash provided by operating activities | -35,108 | -33,794 | -208,801 | - | 12 | 25 | 36 | 35 | 69 | 77 | 68 | 70 |
|---|
| Purchase of land, buildings, and other tangible and intangible assets and liabilities | - | - | - | 150 | 252 | 181 | 255 | 218 | 192 | 151 | 0 | 82 |
|---|
| Proceeds From Sale Of Investment Property | - | - | - | - | - | - | - | - | 5 | 18 | 79 | 57 |
|---|
| Investment in unconsolidated joint venture | - | - | - | - | - | - | - | - | - | - | - | 2 |
|---|
| Escrow deposits for purchase of properties | - | - | - | -104,310 | 0 | -0 | 1 | -0 | -2 | -0 | - | 0 |
|---|
| Advances made to related parties | - | - | - | 137,727 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | -0 |
|---|
| Payment received on loan made to a tenant | - | - | - | - | - | - | - | - | - | 1 | - | - |
|---|
| Capital expenditures on existing real estate investments | - | - | - | - | - | - | - | - | - | - | - | 13 |
|---|
| Leasing commissions | - | - | - | - | - | - | - | - | - | - | 1 | 6 |
|---|
| Net cash used in investing activities | - | - | -32,338,990 | - | -253 | -152 | -258 | -224 | -195 | -137 | 68 | -46 |
|---|
| Proceeds from Issuance of Common Stock | 55,000 | 80,000 | - | - | 34 | 37 | 189 | 53 | 206 | 10 | - | 11 |
|---|
| Escrow deposits required by third party lenders | - | - | - | - | - | - | - | - | - | - | 7 | 0 |
|---|
| Repayment of notes payable | - | - | 349,435 | - | - | - | - | - | - | 1 | 1 | 12 |
|---|
| Payment for CMBS loan defeasance | - | - | - | - | - | - | - | - | - | - | 32 | - |
|---|
| Proceeds from Credit Facility | - | - | - | 28 | - | 186 | 244 | 238 | 222 | 139 | 83 | 144 |
|---|
| Repayment of Credit Facility | - | - | - | - | - | 71 | 173 | 65 | 224 | 16 | 136 | 100 |
|---|
| Payment of debt issuance costs | - | - | - | - | - | - | - | 1 | 6 | 3 | - | - |
|---|
| Dividends paid to common stockholders, and OP Unit and LTIP Unit holders | - | - | - | - | - | - | - | 40 | 53 | 58 | 59 | 60 |
|---|
| Dividends paid to preferred stockholders | - | - | - | 4 | 1 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
|---|
| Net cash provided by financing activities | 55,380 | 80,380 | 41,643,255 | - | 226 | 125 | 224 | 193 | 128 | 62 | -144 | -22 |
|---|
| Net (decrease) increase in cash and cash equivalents and restricted cash | - | - | - | - | - | -2 | 2 | 4 | 2 | 2 | -8 | 2 |
|---|
| Interest Paid, Net | - | - | 1,165,157 | 4 | 6 | 13 | 16 | 17 | 18 | 22 | 30 | 27 |
|---|
| Liabilities Assumed | - | - | - | 4 | 6 | 7 | 11 | 12 | 16 | 16 | 16 | 17 |
|---|
| Interest rate swap agreements fair value change recognized in other comprehensive income | - | - | - | - | - | - | - | 12 | -12 | -41 | 10 | 7 |
|---|
| Units Converted To Common Stock | - | - | - | - | - | - | - | 18 | 1 | 1 | 0 | 1 |
|---|
| Capital Expenditures Incurred but Not yet Paid | - | - | - | - | 11 | 16 | 1 | - | 1 | 1 | 2 | 2 |
|---|
| Stock Issued | - | - | - | 30 | - | - | - | - | - | - | 5 | - |
|---|
| Loans Assumed | - | - | - | - | - | - | - | 12 | - | 2 | - | - |
|---|
| Notes Reduction | - | - | - | - | - | - | - | - | - | - | 0 | - |
|---|